Selected – 2014

Transnational Joint Call for proposals on "InnovaResistance": Innovative approaches to address antibacterial resistance through the JPI on Antimicrobial Resistance

The ANR is associated to the JPI on Antimicrobial Resistance ( to launch the first joint transnational call for funding research projects.

Fourteen countries are participating in this call for proposals: Belgium, Canada, Denmark, France, Germany, Israel, Netherlands, Norway, Poland, Romania, Spain, Sweden, United Kingdom and Turkey.

The primary aim of this first joint call of JPIAMR is to combine the resources, infrastructures, and research strengths of multiple countries in order to overcome antibiotic resistance. The goal is to foster multinational translational research collaborations that can accomplish more than individual countries working independently, leading to improved control of bacterial infections

The call will cover research addressing the following topics:

  • Re-evaluation of existing anti-microbial compounds either alone or in combination with other drugs, immune-modulators or anti-bacterial approaches.
  • Identification of new bacterial targets and/or therapeutic compounds in combination with point-of-care companion diagnostics where relevant.
  • Discovery and implementation of novel therapies to overcome known antimicrobial resistance mechanisms and restore susceptibility to conventional antibiotics. Examples might include studies on novel enzyme or efflux pump inhibitors, as well as studies aimed at understanding and overcoming the mechanisms controlling the generation of resistance.
  • Strategies for optimization of drug use, dosage and delivery of new drugs or drug combinations.
  • Strategies to inhibit or reduce the acquisition of resistance such as single molecular agents effective against multiple targets as well as therapeutics that enhance immune pathogen elimination, disrupt colonization, biofilm development, and virulence.

Excluded sub-topics:

Following topics which directly address the cross-talk between host and pathogens, as well as the relationship between microbes’ environment and infection are excluded. Particularly:

  • Assessing the role of commensal flora in homeostasis and microbe’s pathogenicity, and elucidating how commensal organisms or probiotics can be used to prevent or treat infections.
  • Investigating the initial steps of the infection process.
  • Late stage clinical trials (Phase II and further).

Each proposal must involve a minimum of three countries participating in this call and a maximum of six project participants. Project participants from countries not providing funding to in the call may be involved in projects if they secure their own funding and if their expertise is indispensable for reaching the objectives. The consortia should always consist of a majority of funded project participants. However, the maximum number of six participants may not be exceeded. Project partners from countries not providing funding to in the call cannot be consortium coordinators and must accept all JPIAMR rules and guidelines just as funded members. Each consortium is encouraged to include participants from academia; clinical/public health and industry.

Funding will be awarded for a maximum of three years. The ANR will fund only the French partners in the selected projects.

Opening : 2014-02-06 at 09:53 CET
Pre-proposal deadline : 2014-03-14 at 17:00 CET
Application Deadline : 2014-07-21 at 17:00 CEST


The call is centrally coordinated by the Joint Call Secretariat (JCS) for "InnovaResistance", which is represented by Forschungszentrum Jülich GmbH (Project Management Jülich, PtJ, Jülich, Germany) and Canadian Institutes of Health Research (CIHR).

Submissions of proposals will be in two steps. All proposals should be submitted online via the submission website before the respective deadlines (pre-proposals March 14th, 2014, 17:00 CEST; full proposals July 21st, 2014, 17:00 CEST). Only invited pre-proposals will be accepted for full proposal submission.

Each French partner of the selected projects will sign a grant agreement with the ANR. Therefore, he/she will adhere to the methods stipulated in "Regulations concerning the conditions of allocation of ANR funding ", which may be consulted on the ANR website (



Joint Call Secretariat (JCS) for “InnovaResistance”

Dr. Bülent Genç
+49 (0) 2461 61 5265

Dr. Henrike Knizia,
+49 (0) 2461 61 9758


Dr. Serawit Bruck-Landais
Tel : 01 73 54 81 70


Consult the upcoming and current calls of the portal

The portal centralises all information on calls for proposals and calls for applications from ADEME, ANR, Inserm including ANRS, Anses and INCa. It provides a simplified access to upcoming and ongoing calls, giving a greater visibility to funding opportunities. Following their closing date, the calls remain published for a few months.


Sign up for the latest news:
Subscribe to our newsletter